Disease | uveitis |
Phenotype | C0024440|cystoid macular edema |
Sentences | 3 |
PubMedID- 25135585 | If the third measurement is reliable, the difference of the value from the first or second measurement is up to 3 db, and visual field abnormality is recognized in the two measurementsocular exclusion criteria (applies to the eye evaluated) 1. under treatment for glaucoma or ocular hypertension 2. either eye enucleated or eviscerated 3. cone-rod dystrophy with primarily impaired cone function 4. history of other ocular disease that can confound the outcome of the study (e.g., diabetic retinopathy, uveitis) 5. complicated by remarkable cystoid macular edema, epimacular membrane, or macular traction syndrome, diagnosed by oct 6. complicated by a nuclear cataract of moderate grade (grade 3, emery classification), an anterior subcapsular cataract, or a posterior subcapsular cataract, that may seriously affect vision 7. |
PubMedID- 20337324 | The case of a 44-year-old woman who was under treatment for bilateral recurrent anterior uveitis with chronic cystoid macular edema for two and a half years. |
PubMedID- 24347829 | In one retrospective study, tocilizumab was found to be efficacious in treating uveitis patients with cystoid macular edema that was refractory to intraocular steroids or other immunosuppressive therapies [25]. |
Page: 1